WO2000027206A1 - Antimicrobial composition comprising leptospermum scoparium and melaleuca alternifolia oils - Google Patents
Antimicrobial composition comprising leptospermum scoparium and melaleuca alternifolia oils Download PDFInfo
- Publication number
- WO2000027206A1 WO2000027206A1 PCT/NZ1999/000194 NZ9900194W WO0027206A1 WO 2000027206 A1 WO2000027206 A1 WO 2000027206A1 NZ 9900194 W NZ9900194 W NZ 9900194W WO 0027206 A1 WO0027206 A1 WO 0027206A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- antimicrobial composition
- melaleuca alternifolia
- fractions
- leptospermum scoparium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/28—Myrtaceae [Myrtle family], e.g. teatree or clove
Definitions
- This invention relates to improvements in and relating to antimicrobial 5 compositions. More particularly, it relates to antimicrobial compositions comprising or including a mixture of oils of melaleuca alternifolia and leptospermum scoparium and/or fractions/dilutions of same.
- manuka is the most abundant and widely distributed flowering native tree in New Zealand. It was historically used in New Zealand by Maori and later European settlers for purposes including the treatment of respiratory ailments, burns, dandruff, dysentery, fever, and indigestion, as well as being drunk as a type of tea.
- the biologically active ingredient is the oil accumulated in oil glands in the leaves. Whilst research 3 indicates that there may
- the present invention relates to all New Zealand chemotypes, although particular reference is made to manuka derived from the East Cape region of New Zealand.
- the tea tree is a completely different species to the Australian tea tree (melaleuca alternifolia).
- a method of preparing a broad spectrum antimicrobial composition comprising combining the oils of leptospermum scoparium and melaleuca alternifolia.
- a method of preparing an antimicrobial composition substantially as described above, to have effect against a targeted microbe comprising altering the proportions of the constituent leptospermum scoparium or melaleuca alternifolia oils as appropriate to specifically target said targeted microbe.
- the proportions of the respective oils may each range between 1 - 99%, by volume, but may preferably fall within the range of substantially 30 - 70% respectively depending on the targeted microbe.
- Each or both of the two oils may be present in "increased” or "lessor” amounts, proportionally, depending on the targeted microbes.
- a method of preparing an antimicrobial composition substantially as described above, for having effect against gram negative microbes by increasing the proportion of melaleuca alternifolia in the composition.
- a method of preparing an antimicrobial composition substantially as described above, for having effect against gram positive microbes by increasing the proportion of leptospermum scoparium oil in the composition.
- a method of increasing the potency of the broad-spectrum antimicrobial composition comprising the step of extracting high potency fractions of the oils and incorporating them into the composition.
- the high potency fractions may be used in whole or diluted form and in combination or singly. According to further aspects of the present invention there is provided broad spectrum antimicrobial compositions, produced according to the above methods.
- an antimicrobial composition substantially as described above, containing a fraction of melaleuca alternifolia oil having high potency, as defined hereinafter. According to a further aspect of the present invention there is provided an antimicrobial composition substantially as described above comprising predominantly enhanced terpinen-4-ol.
- an antimicrobial composition containing a fraction of melaleuca alternifolia oil having lower potency, as defined hereinafter.
- an antimicrobial composition substantially as described above comprising predominantly compounds selected from one or more of the following group: pinenes, myrcene, 2-carene, limonene, gamma terpinen and lower levels of Terpinen-4-ol.
- an antimicrobial composition containing a fraction of leptospermum scoparium having high potency, as defined hereinafter.
- an antimicrobial composition substantially as described above comprising predominantly enhanced levels of flavesone, isoleptospermone and leptospermone.
- an antimicrobial composition containing a fraction of leptospermum scoparium having lower potency, as defined hereinafter. According to a further aspect of the present invention there is provided an antimicrobial composition substantially as described above comprising predominantly lower levels of monoterpines and/or lower concentrations of flavesone, isoleptospermone and leptospermone.
- Combinations and dilutions of the above whole oils, fractions or dilutions thereof and/or combinations thereof are also within the scope of the present invention given the hitherto unknown finding that the said combinations provide a novel and effective broad spectrum antimicrobial composition.
- Melaleuca alternifolia oil is relatively more potent at killing gram negative organisms eg Eschericia coli, than is leptospermum scoparium oil.
- Leptospermum scoparium oil however is found to be relatively more potent at killing gram positive organisms eg Staphylococcus Aureus, than is melaleuca alternifolia oil (see Table 2).
- An aspect of the present invention is the production of an antimicrobial composition (in the form of an oil) with a unique and surprisingly broad spectrum and selective potency against a wide range of micro-organisms. This is achieved in one embodiment by mixing whole melaleuca alternifolia oil with whole leptospermum scoparium oil at varying concentrations (Table 3).
- particular fractions of the oils of both species may be extracted and combined according to the desired spectrum of the fractions and the potency required and/or the microbes to be targeted.
- the most potent components that is "high potency" of leptospermum scoparium oil against microorganisms, according to GC, occur approximately between RI 1482 and 1610 (Table 5). These components can alternatively be characterised as or include fractions containing enhanced levels of Flavesone, Isoleptospermone and Leptospermone.
- the term “enhanced” means an increased amount over the whole base oil.
- RI components in the case of leptospermum scoparium oil between approximately 920 and 1476 namely fractions containing compounds selected from the group comprising monoterpines and low concentrations of Flavesone, Isoleptospermone and Leptospermone retain "low potency" antimicrobial action and may still be useful on their own or in mixtures with other oil fractions (Table 7).
- the low potency fractions of both species may be used where the antimicrobial effect of the preparation is required to be less potent, perhaps in cosmetic treatments, mild antibacterial face washes and the treatment of minor medical ailments, or for non-human applications.
- the low potency fractions may be used to supplement other higher potency fractions.
- high potency oil the high potency fractions of melaleuca alternifolia oil are mixed with the high potency fractions of leptospermum scoparium oil (Table 8 and Table 9). The measuring and mixing may be achieved in any manner known in the art, and utilise any desired quantity ratios or concentration of the oil fractions.
- the proportions of the mixtures as discussed above can be varied to change the degree of potency against any particular group of microbes. Again, no strict formula applies in terms of changing proportions as it will be apparent to the art skilled worker, and having regard to Table 8 and Table 9, what degree of variation may be required in relation to a desired end usage. For example, as shown in Table 8 by decreasing the percentage of the high potency melaleuca alternifolia oil fraction (RI 920 - 1142), and increasing the percentage of high potency leptospermum scoparium oil fraction (RI 1482 - 1610), the resultant oil mixture is more potent against gram positive organisms eg Staphylococcus Aureus.
- Fractions of the oils are produced by any known fractionation method, for example supercritical CO 2 , molecular distillation, steam stripping and solvent fractionation. Depending on the proportion of fractions of both oils mixed together, the concentrations and characteristics of the original oils may be altered. Particularly, where 90% high potency fraction of melaleuca alternifolia oil with 10% high potency fraction of leptospermum scoparium oil (Table 9) is used, a broad spectrum, high potency (and reduced perfume) composition is produced.
- the present invention relates to methods of combining melaleuca alternifolia oil and leptospermum scoparium oil, or any combination of said whole oils, dilutions or fractions, to produce compositions with varying spectrum, and activity against microorganisms. This is highly advantageous over prior art existing uses of whole oils individually.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
This invention relates to improvements in and relating to antimicrobial compositions. More particularly, it relates to antimicrobial compositions comprising or including a mixture of oils of melaleuca alternifolia and leptospermum scoparium and/or fractions or dilutions of same. A method of producing the composition is also claimed, as are methods of producing compositions which target particular microbes.
Description
ANTIMICROBIAL COMPOSITION COMPRISING LEPTOSPERMUM SCOPARIUM AND MELALEUCA ALTERNIFOLIA
TECHNICAL FIELD
This invention relates to improvements in and relating to antimicrobial 5 compositions. More particularly, it relates to antimicrobial compositions comprising or including a mixture of oils of melaleuca alternifolia and leptospermum scoparium and/or fractions/dilutions of same.
BACKGROUND ART
In recent years increased effort has been devoted to investigating and isolating 0 commercially useful extracts from native plants and animals internationally. In some respects this has been motivated by continuing resistance developed by infective organisms and diseases to conventional therapies but also by a desire to extract full benefit from the world's resources. In some cases the biological organism can be chemically active in its raw state, but more usually isolation or 5 other treatment is necessitated to release the therapeutic and/or prophylactic effects. In New Zealand, essential oils have been extracted from New Zealand manuka tree (leptospermum scoparium) on a commercial basis for some years although the industry continues to grow. Manuka oil has been used to date in various applications including aromatherapy, cosmetics1 and as a toothpaste 0 ingredient. According to one source2 manuka is the most abundant and widely distributed flowering native tree in New Zealand. It was historically used in New Zealand by Maori and later European settlers for purposes including the treatment of respiratory ailments, burns, dandruff, dysentery, fever, and indigestion, as well as being drunk as a type of tea. The biologically active ingredient is the oil accumulated in oil glands in the leaves. Whilst research3 indicates that there may
1 Kennedy & Myleck (1998) A Downunder Perspective on Botanicals in Cosmetics, Botanicals in Cosmetics, Marcel Dekker Inc., Impress (1998)
2 Perry et al, Essential Oils from New Zealand Manuka and Kanuka: Chemotexonomy of Leptospermum, Phytochemistry 44(8): 1485 to 1495 (1997)
3 Perry et al 1997 as above
be different chemotypes of manuka in New Zealand, the present invention relates to all New Zealand chemotypes, although particular reference is made to manuka derived from the East Cape region of New Zealand.
Manuka, whilst colloquially known in New Zealand as "the tea tree" is a completely different species to the Australian tea tree (melaleuca alternifolia).
Given the prevalence of the manuka and Australian tea trees in their respective countries, together with a wish to further investigate the biological properties of these species, it would be desirable to identify and apply the biological properties in a commercially and biologically useful manner. It is an object of the present invention to address the foregoing problems or at least to provide the public with a useful choice.
Further aspects and advantages of the present invention will become apparent from the ensuing description, which is given by way of example only.
DISCLOSURE OF INVENTION According to one aspect of the present invention there is provided a method of preparing a broad spectrum antimicrobial composition comprising combining the oils of leptospermum scoparium and melaleuca alternifolia.
Use of the combination is clearly highly advantageous over use of the whole oils individually. In addition to whole oils, active (that is, having microbial activity or activity against microbes) antimicrobial dilutions and/or fractions of same are within the scope of the present invention.
Conventional oil extraction methods are well known, and may be used to extract the oils, or fractions of same, from the two trees or species. According to another aspect of the present invention there is provided a method of preparing an antimicrobial composition, substantially as described above, to have effect against a targeted microbe comprising altering the proportions of the constituent leptospermum scoparium or melaleuca alternifolia oils as appropriate to specifically target said targeted microbe.
The proportions of the respective oils may each range between 1 - 99%, by volume, but may preferably fall within the range of substantially 30 - 70% respectively depending on the targeted microbe. Each or both of the two oils may be present in "increased" or "lessor" amounts, proportionally, depending on the targeted microbes.
According to another aspect of the present invention there is provided a method of preparing an antimicrobial composition, substantially as described above, for having effect against gram negative microbes by increasing the proportion of melaleuca alternifolia in the composition. According to another aspect of the present invention there is provided a method of preparing an antimicrobial composition, substantially as described above, for having effect against gram positive microbes by increasing the proportion of leptospermum scoparium oil in the composition.
According to another aspect of the present invention there is provided a method of increasing the potency of the broad-spectrum antimicrobial composition, substantially as described above, comprising the step of extracting high potency fractions of the oils and incorporating them into the composition.
The high potency fractions may be used in whole or diluted form and in combination or singly. According to further aspects of the present invention there is provided broad spectrum antimicrobial compositions, produced according to the above methods.
According to a further aspect of the present invention there is provided an antimicrobial composition substantially as described above, containing a fraction of melaleuca alternifolia oil having high potency, as defined hereinafter. According to a further aspect of the present invention there is provided an antimicrobial composition substantially as described above comprising predominantly enhanced terpinen-4-ol.
According to a further aspect of the present invention there is provided an antimicrobial composition containing a fraction of melaleuca alternifolia oil having lower potency, as defined hereinafter.
According to a further aspect of the present invention there is provided an antimicrobial composition substantially as described above comprising predominantly compounds selected from one or more of the following group: pinenes, myrcene, 2-carene, limonene, gamma terpinen and lower levels of Terpinen-4-ol.
According to a further aspect of the present invention there is provided an antimicrobial composition, containing a fraction of leptospermum scoparium having high potency, as defined hereinafter.
According to a further aspect of the present invention there is provided an antimicrobial composition substantially as described above comprising predominantly enhanced levels of flavesone, isoleptospermone and leptospermone.
According to another aspect of the present invention there is provided an antimicrobial composition containing a fraction of leptospermum scoparium having lower potency, as defined hereinafter. According to a further aspect of the present invention there is provided an antimicrobial composition substantially as described above comprising predominantly lower levels of monoterpines and/or lower concentrations of flavesone, isoleptospermone and leptospermone.
Combinations and dilutions of the above whole oils, fractions or dilutions thereof and/or combinations thereof are also within the scope of the present invention given the hitherto unknown finding that the said combinations provide a novel and effective broad spectrum antimicrobial composition.
Applications of same including those relating to antimicrobial treatments in general together with those relating to the treatment or prevention of minor microbial related ailments or conditions in humans are also within the scope of the present invention.
EXAMPLES
Further aspects of the present invention will become apparent from the following description that is given by way of example only and with reference to the accompanying tables:
Table 1 - Greatest Dilution Showing Microcidal Effect
Table 2 - Greatest Dilution Showing Microcidal Effect
Table 3 - Greatest Dilution Showing Microcidal Effect for a Mixture of Equal Parts of Melaleuca alternifolia and Leptospermum scoparium Oils
Table 4 - Greatest Dilution Showing Microcidal Effect for High Potencv Melaleuca alternifolia Fraction
Table 5 - Greatest Dilution Showing Microcidal Effect for High Potency Leptospermum scoparium Fraction
Table 7 - Greatest Dilution Showing Microcidal Effect for Low Potency Leptospermum scoparium Fraction "7"
Table 8 - Greatest Dilution Showing Microcidal Effect for Narving Concentrations of High Potencv Melaleuca alternifolia and Leptospermum scoparium Fractions
Melaleuca alternifolia and 10% Leptospermum scoparium Fraction "8" compared to 100% Melaleuca alternifolia and 100% Leptospermum scoparium oils
BEST MODES OF CARRYING OUT THE INVENTION
Both the essential oils prepared from melaleuca alternifolia and leptospermum scoparium kill, to a greater or lesser extent, a wide range of microorganisms as is shown in Table 1.
The applicant has found that Melaleuca alternifolia oil is relatively more potent at killing gram negative organisms eg Eschericia coli, than is leptospermum
scoparium oil. Leptospermum scoparium oil however is found to be relatively more potent at killing gram positive organisms eg Staphylococcus Aureus, than is melaleuca alternifolia oil (see Table 2).
An aspect of the present invention is the production of an antimicrobial composition (in the form of an oil) with a unique and surprisingly broad spectrum and selective potency against a wide range of micro-organisms. This is achieved in one embodiment by mixing whole melaleuca alternifolia oil with whole leptospermum scoparium oil at varying concentrations (Table 3).
According to another embodiment of the present invention, particular fractions of the oils of both species may be extracted and combined according to the desired spectrum of the fractions and the potency required and/or the microbes to be targeted.
For example, it appears that the most potent components (that is "high potency") of melaleuca alternifolia oil against microorganisms, according to gas chromatography (GC), occur between approximately relative index (RI), 920 and 1142 (Table 4). These components can alternatively be characterised as fractions containing enhanced Terpinen-4-ol levels.
Further, the most potent components (that is "high potency") of leptospermum scoparium oil against microorganisms, according to GC, occur approximately between RI 1482 and 1610 (Table 5). These components can alternatively be characterised as or include fractions containing enhanced levels of Flavesone, Isoleptospermone and Leptospermone.
In the context of this specification, the term "enhanced" means an increased amount over the whole base oil. RI components in the case of melaleuca alternifolia oil between approximately 1179 and 1610, namely fractions containing compounds selected from the group
comprising pinene, myrcene, limonene, gamma terpinene and lower levels of terpinen-4-ol, retain "low potency" antimicrobial action and may still be useful on their own or in mixtures with other oil fractions (Table 6).
RI components in the case of leptospermum scoparium oil between approximately 920 and 1476, namely fractions containing compounds selected from the group comprising monoterpines and low concentrations of Flavesone, Isoleptospermone and Leptospermone retain "low potency" antimicrobial action and may still be useful on their own or in mixtures with other oil fractions (Table 7).
It will accordingly be appreciated that the low potency fractions of both species may be used where the antimicrobial effect of the preparation is required to be less potent, perhaps in cosmetic treatments, mild antibacterial face washes and the treatment of minor medical ailments, or for non-human applications. Alternatively the low potency fractions may be used to supplement other higher potency fractions. To create a broad spectrum "high potency oil", the high potency fractions of melaleuca alternifolia oil are mixed with the high potency fractions of leptospermum scoparium oil (Table 8 and Table 9). The measuring and mixing may be achieved in any manner known in the art, and utilise any desired quantity ratios or concentration of the oil fractions. The proportions of the mixtures as discussed above can be varied to change the degree of potency against any particular group of microbes. Again, no strict formula applies in terms of changing proportions as it will be apparent to the art skilled worker, and having regard to Table 8 and Table 9, what degree of variation may be required in relation to a desired end usage. For example, as shown in Table 8 by decreasing the percentage of the high potency melaleuca alternifolia oil fraction (RI 920 - 1142), and increasing the percentage of high potency leptospermum scoparium oil fraction (RI 1482 - 1610), the resultant oil mixture is more potent against gram positive organisms eg Staphylococcus Aureus. Similarly, by increasing the percentage of the high potency melaleuca alternifolia oil fraction (RI 920-1142) and decreasing the percentage of the high potency leptospermum scoparium oil fraction (RI 1482 - 1610) the resultant oil mixture is
more potent against gram negative organisms eg Escherecia Coli. Quantities in this example varied by up to 15% from equal quantities but quantities between 1 - 99% of each oil respectively are within the scope of the present invention.
Fractions of the oils are produced by any known fractionation method, for example supercritical CO2, molecular distillation, steam stripping and solvent fractionation. Depending on the proportion of fractions of both oils mixed together, the concentrations and characteristics of the original oils may be altered. Particularly, where 90% high potency fraction of melaleuca alternifolia oil with 10% high potency fraction of leptospermum scoparium oil (Table 9) is used, a broad spectrum, high potency (and reduced perfume) composition is produced.
It can be seen that the present invention relates to methods of combining melaleuca alternifolia oil and leptospermum scoparium oil, or any combination of said whole oils, dilutions or fractions, to produce compositions with varying spectrum, and activity against microorganisms. This is highly advantageous over prior art existing uses of whole oils individually.
Aspects of the present invention have been described by way of example only and it should be appreciated that modifications and additions may be made thereto without departing from the scope thereof as defined in the appended claims.
Claims
THE CLAIMS DEFINING THE INVENTION ARE:
1 A method of preparing a broad spectrum antimicrobial composition comprising combining the oils of leptospermum scoparium and melaleuca alternifolia.
2 A method as claimed in claim 1, comprising combining dilutions and/or fractions of said oils.
3 A method as claimed in claim 1 or claim 2 wherein the proportion of leptospermum scoparium oil or melaleuca alternifolia oil falls within the range of substantially 30% to 70%, by volume, of the composition. A method as claimed in any one of claims 1 to 3, said method comprising the step of altering the proportions of the constituent leptospermum scoparium and/or melaleuca alternifolia oils to target specific organism(s) or microbe(s). A method as claimed in claim 4, wherein the proportion of melaleuca alternifolia oil in the composition is higher than that of leptospermum scoparium in order to target gram negative microbes. A method as claimed in claim 4, wherein of the proportion of leptospermum scoparium oil is higher than that of melaleuca alternifolia in order to target gram positive microbes. A method of increasing the overall potency of the broad spectrum antimicrobial composition as claimed in any one of claims 1 to 3 comprising extracting high potency fractions of melaleuca alternifolia oil and/or leptospermum scoparium oil and incorporating them into the composition. A method as claimed in claim 7 wherein the high potency fractions are used in whole or diluted form and in combination together or individually in the composition. A broad spectrum antimicrobial composition comprising a combination of the oils of leptospermum scoparium and melaleuca alternifolia.
A broad spectrum antimicrobial composition as claimed in claim 9 comprising a combination of high potency fractions of melaleuca alternifolia oil and/or leptospermum scoparium oil, in whole or diluted form. A broad spectrum antimicrobial composition as claimed in claim 9 comprising a combination of low potency fractions of melaleuca alternifolia oil and/or leptospermum scoparium in whole or diluted form. A method of treating a microbial infection comprising administering the composition as claimed in any one of claims 9 to 11. An antimicrobial composition as claimed in claim 10 comprising 45% (by volume) of high potency melaleuca alternifolia and 55% (by volume) of high potency leptospermum scoparium oil. An antimicrobial composition as claimed in claim 10 potency leptospermum scoparium oil. An antimicrobial composition as claimed in claim 10 comprising 60% of high potency melaleuca alternifolia and 40% of high potency leptospermum scoparium oil. An antimicrobial composition as claimed in claim 10 comprising 65% of high potency melaleuca alternifolia and 35% of high potency leptospermum scoparium oil. An antimicrobial composition as claimed in claim 9 comprising 90% melaleuca alternifolia oil and 10% of potency leptospermum scoparium oil. A broad spectrum anti-microbial composition as claimed in claim 10 wherein the high potency fractions of melaleuca alternifolia oil have an RI of between 920 and 1142. A broad spectrum antimicrobial composition as claimed in claim 10 wherein the high potency fractions of melaleuca alternifolia oil include Terpinen-4-ol.
A broad spectrum antimicrobial composition as claimed in claim 10 wherein the high potency fractions of leptospermum scoparium oil have an RI of between 1482 and 1610. A broad spectrum antimicrobial composition as claimed in claim 10 wherein the high potency fractions of leptospermum scoparium oil include Flavesone, Isoleptospermone and Leptospermone. A broad spectrum antimicrobial composition as claimed in claim 11 wherein the low potency fractions of melaleuca alternifolia oil have an RI of between 1179 and 1610. A broad spectrum antimicrobial composition as claimed in claim 11 wherein the low potency fractions of melaleuca alternifolia oil include compounds selected from the following group: pinene, myrcene, limonene, gamma terpinene and/or lower levels of terpinen-4-ol. A broad spectrum antimicrobial composition as claimed in claim 11 wherein the low potency fractions of leptospermum scoparium oil have an RI of between 920 and 1476. A broad spectrum antimicrobial composition as claimed in claim 11 wherein the low potency fractions of leptospermum scoparium oil include monoterpins and/or low concentrations of Flavesone, Isoleptospermone and Leptospermone. A broad spectrum antimicrobial composition as claimed in claim 9 comprising a combination of high potency fractions and low potency fractions of the melaleuca alternifolia oil and/or leptospermum scoparium oil. A method of preparing a broad spectrum antimicrobial composition as claimed in any one of claims 1 to 8, substantially as hereindescribed and/or with respect to any example thereof. An antimicrobial composition substantially as herein described and/or with respect to any examples thereof.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002349895A CA2349895A1 (en) | 1998-11-06 | 1999-11-05 | Antimicrobial composition comprising leptospermum scoparium and melaleuca alternifolia oils |
| US09/831,053 US6514539B1 (en) | 1998-11-06 | 1999-11-05 | Antimicrobial composition comprising Leptospermum scoparium and Melaleuca alternifolia oils |
| EP99971667A EP1126759A4 (en) | 1998-11-06 | 1999-11-05 | Antimicrobial composition comprising leptospermum scoparium) and melaleuca alternifolia oils |
| AU14182/00A AU768249B2 (en) | 1998-11-06 | 1999-11-05 | Antimicrobial composition comprising Leptospermum scoparium and Melaleuca alternifolia oils |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ332694 | 1998-11-06 | ||
| NZ332694A NZ332694A (en) | 1998-11-06 | 1998-11-06 | Antimicrobial composition containing manuka oil (leptospermum scoparium) and Australian tea tree oil (melaleuca alternifolia) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2000027206A1 true WO2000027206A1 (en) | 2000-05-18 |
Family
ID=19927002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/NZ1999/000194 Ceased WO2000027206A1 (en) | 1998-11-06 | 1999-11-05 | Antimicrobial composition comprising leptospermum scoparium and melaleuca alternifolia oils |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6514539B1 (en) |
| EP (1) | EP1126759A4 (en) |
| AU (1) | AU768249B2 (en) |
| CA (1) | CA2349895A1 (en) |
| NZ (1) | NZ332694A (en) |
| WO (1) | WO2000027206A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002089587A1 (en) * | 2001-05-08 | 2002-11-14 | Bioprospect Limited | Methods and compositions for controlling pests |
| GB2406053B (en) * | 2003-09-10 | 2008-08-20 | Micap Plc | Antimicrobial composition |
| WO2010016777A1 (en) * | 2008-08-08 | 2010-02-11 | Robert Arthur Franich | Fractionation and modification of natural essential oils containing beta-triketones |
| CN109937035A (en) * | 2016-06-21 | 2019-06-25 | 堪培拉大学 | Antiparasitic compositions and methods |
| WO2021024211A1 (en) * | 2019-08-05 | 2021-02-11 | Manuka Therapeutics Ltd. | Antimicrobial topical compositions containing manuka oil |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6485711B1 (en) * | 2002-03-21 | 2002-11-26 | Michael J. Olmstead | Organic toothpaste containing saponin |
| US7258876B2 (en) * | 2003-02-05 | 2007-08-21 | Craig Bozzacco | Topical composition for treating infectious conditions of skin and mucosa |
| US20050013882A1 (en) * | 2003-04-16 | 2005-01-20 | Jacques Owen | Phyto fluid |
| US20120208877A1 (en) * | 2011-02-14 | 2012-08-16 | James C. Caillouette | Skin treatment in antiseptic thin film form with silver |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19631037A1 (en) * | 1996-08-01 | 1998-02-05 | Boehringer Ingelheim Vetmed | Formulation of bactericide and terpene-containing plant extract |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO583597A0 (en) * | 1997-03-24 | 1997-04-24 | Mainstar One Investments Pty Ltd | Preservative composition containing tea tree oil |
| US5906825A (en) * | 1997-10-20 | 1999-05-25 | Magellan Companies, Inc. | Polymers containing antimicrobial agents and methods for making and using same |
| DE29719141U1 (en) * | 1997-10-29 | 1997-12-11 | Eduard Gerlach GmbH, 32312 Lübbecke | Personal care products, in particular deodorant |
-
1998
- 1998-11-06 NZ NZ332694A patent/NZ332694A/en unknown
-
1999
- 1999-11-05 EP EP99971667A patent/EP1126759A4/en not_active Ceased
- 1999-11-05 AU AU14182/00A patent/AU768249B2/en not_active Ceased
- 1999-11-05 US US09/831,053 patent/US6514539B1/en not_active Expired - Fee Related
- 1999-11-05 CA CA002349895A patent/CA2349895A1/en not_active Abandoned
- 1999-11-05 WO PCT/NZ1999/000194 patent/WO2000027206A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19631037A1 (en) * | 1996-08-01 | 1998-02-05 | Boehringer Ingelheim Vetmed | Formulation of bactericide and terpene-containing plant extract |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002089587A1 (en) * | 2001-05-08 | 2002-11-14 | Bioprospect Limited | Methods and compositions for controlling pests |
| JP2004534021A (en) * | 2001-05-08 | 2004-11-11 | バイオプロスペクト リミティッド | Methods and compositions for controlling pests |
| US7820209B2 (en) | 2001-05-08 | 2010-10-26 | Bioprospect Limited | Methods and compositions for controlling pests |
| US9474270B2 (en) | 2001-05-08 | 2016-10-25 | Bioprosepect Limited | Methods and compositions for controlling pests |
| GB2406053B (en) * | 2003-09-10 | 2008-08-20 | Micap Plc | Antimicrobial composition |
| WO2010016777A1 (en) * | 2008-08-08 | 2010-02-11 | Robert Arthur Franich | Fractionation and modification of natural essential oils containing beta-triketones |
| CN109937035A (en) * | 2016-06-21 | 2019-06-25 | 堪培拉大学 | Antiparasitic compositions and methods |
| EP3471710A4 (en) * | 2016-06-21 | 2019-12-18 | University of Canberra | PEST CONTROL COMPOSITIONS AND METHODS |
| WO2021024211A1 (en) * | 2019-08-05 | 2021-02-11 | Manuka Therapeutics Ltd. | Antimicrobial topical compositions containing manuka oil |
Also Published As
| Publication number | Publication date |
|---|---|
| NZ332694A (en) | 2001-03-30 |
| AU768249B2 (en) | 2003-12-04 |
| AU1418200A (en) | 2000-05-29 |
| US6514539B1 (en) | 2003-02-04 |
| EP1126759A1 (en) | 2001-08-29 |
| EP1126759A4 (en) | 2002-04-24 |
| CA2349895A1 (en) | 2000-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bağdat et al. | The essential oil of lemon balm (Melissa officinalis L.), its components and using fields | |
| DE69602529T2 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING PLANT ACTIVE ACTIVE SUBSTANCES, METHOD FOR THE PRODUCTION AND USE OF THEM FOR MEDICAL AND VETERINARY PURPOSES | |
| CN103891782B (en) | A kind of bactericidal composition, its preparation method and its purposes in anti-bacteria paper preparation | |
| Puvača et al. | Antimicrobial, antioxidant and acaricidal properties of tea tree (Melaleuca alternifolia) | |
| KR20000001148A (en) | Essential oil composition having functions of antibiosis and antifungus | |
| CN104094977A (en) | Composition with insect-expelling sterilization disinfection effects and application thereof | |
| CN105199462A (en) | Plant sterilizing insect-repelling functional type inner wall emulsion paint and preparation method thereof | |
| AU768249B2 (en) | Antimicrobial composition comprising Leptospermum scoparium and Melaleuca alternifolia oils | |
| KR20120025740A (en) | Natural anti-bacterial composition and spray solution containing the same | |
| Yangui et al. | Biological properties and chemical composition of essential oils from fresh and shade dried olive leaves of Olea europaea L. Chemlali Cultivar | |
| KR20080081633A (en) | Antibacterial Soap Composition | |
| KR101993375B1 (en) | Perfume composition having the fragrnace of flower of rosmarinus officinalis | |
| KR102223359B1 (en) | Cosmetic composition for preventing skin aging containing hemp and method for manufacturing the same | |
| Al-Ghamdi et al. | Total phenolic content, antioxidant and antimicrobial activity of Ruta chalepensis L. leaf Extract in Al-Baha area, Saudi Arabia | |
| CN110628517A (en) | Natural edible detergent and preparation method thereof | |
| CN117859773A (en) | Natural antibacterial mite-killing composition and preparation method and application thereof | |
| KR20140056966A (en) | Fragrance composition with antiseptic activity and cosmetic composition comprising thereof | |
| KR101680854B1 (en) | A composition comprising extracts of Cinnamomum camphora and Torilis japonica for inhibiting phytophthora blight | |
| AU2021223379A1 (en) | Plant protection agent | |
| KR20110120481A (en) | Natural preservative cosmetic composition containing kimchi lactic acid bacteria fermentation broth and willow bark extract as antibacterial ingredient | |
| HH Ismaiel | Benefiting from the essential oil extracted from the leaves of the camphor tree (Cinnamomum camphora L.) as a food preservative. | |
| US11185493B1 (en) | Betel leaf extract composition has bactericidal and antiviral properties and method of manufacturing the same | |
| Sridhar | Nature's shield: The promise of herbal hand sanitizers | |
| CN109609300A (en) | Agarwood essential oil soap | |
| CN110205213A (en) | A kind of perfumed soap and preparation method thereof with bactericidal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENP | Entry into the national phase |
Ref country code: AU Ref document number: 2000 14182 Kind code of ref document: A Format of ref document f/p: F |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| ENP | Entry into the national phase |
Ref document number: 2349895 Country of ref document: CA Ref country code: CA Ref document number: 2349895 Kind code of ref document: A Format of ref document f/p: F |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1999971667 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 14182/00 Country of ref document: AU |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09831053 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 1999971667 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWG | Wipo information: grant in national office |
Ref document number: 14182/00 Country of ref document: AU |
|
| WWR | Wipo information: refused in national office |
Ref document number: 1999971667 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1999971667 Country of ref document: EP |